171 related articles for article (PubMed ID: 37880206)
21. Route of antigen uptake differentially impacts presentation by dendritic cells and activated monocytes.
Kamphorst AO; Guermonprez P; Dudziak D; Nussenzweig MC
J Immunol; 2010 Sep; 185(6):3426-35. PubMed ID: 20729332
[TBL] [Abstract][Full Text] [Related]
22. Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8- dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells.
Pooley JL; Heath WR; Shortman K
J Immunol; 2001 May; 166(9):5327-30. PubMed ID: 11313367
[TBL] [Abstract][Full Text] [Related]
23. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
[TBL] [Abstract][Full Text] [Related]
24. Active dissemination of cellular antigens by DCs facilitates CD8
Gurevich I; Feferman T; Milo I; Tal O; Golani O; Drexler I; Shakhar G
Eur J Immunol; 2017 Oct; 47(10):1802-1818. PubMed ID: 28872666
[TBL] [Abstract][Full Text] [Related]
25. Rational design of nanoparticles towards targeting antigen-presenting cells and improved T cell priming.
Zupančič E; Curato C; Paisana M; Rodrigues C; Porat Z; Viana AS; Afonso CAM; Pinto J; Gaspar R; Moreira JN; Satchi-Fainaro R; Jung S; Florindo HF
J Control Release; 2017 Jul; 258():182-195. PubMed ID: 28511928
[TBL] [Abstract][Full Text] [Related]
26. Increased antigen presentation efficiency by coupling antigens to MHC class I trafficking signals.
Kreiter S; Selmi A; Diken M; Sebastian M; Osterloh P; Schild H; Huber C; Türeci O; Sahin U
J Immunol; 2008 Jan; 180(1):309-18. PubMed ID: 18097032
[TBL] [Abstract][Full Text] [Related]
27. Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells.
Unger WW; van Beelen AJ; Bruijns SC; Joshi M; Fehres CM; van Bloois L; Verstege MI; Ambrosini M; Kalay H; Nazmi K; Bolscher JG; Hooijberg E; de Gruijl TD; Storm G; van Kooyk Y
J Control Release; 2012 May; 160(1):88-95. PubMed ID: 22366522
[TBL] [Abstract][Full Text] [Related]
28. CD4 T cell help is required for primary CD8 T cell responses to vesicular antigen delivered to dendritic cells in vivo.
Serre K; Giraudo L; Siret C; Leserman L; Machy P
Eur J Immunol; 2006 Jun; 36(6):1386-97. PubMed ID: 16673447
[TBL] [Abstract][Full Text] [Related]
29. Anatomic location and T-cell stimulatory functions of mouse dendritic cell subsets defined by CD4 and CD8 expression.
McLellan AD; Kapp M; Eggert A; Linden C; Bommhardt U; Bröcker EB; Kämmerer U; Kämpgen E
Blood; 2002 Mar; 99(6):2084-93. PubMed ID: 11877283
[TBL] [Abstract][Full Text] [Related]
30. Microfluidic Squeezing Enables MHC Class I Antigen Presentation by Diverse Immune Cells to Elicit CD8
Booty MG; Hlavaty KA; Stockmann A; Ozay EI; Smith C; Tian L; How E; Subramanya D; Venkitaraman A; Yee C; Pryor O; Volk K; Blagovic K; Vicente-Suarez I; Yarar D; Myint M; Merino A; Chow J; Abdeljawad T; An H; Liu S; Mao S; Heimann M; Talarico L; Jacques MK; Chong E; Pomerance L; Gonzalez JT; von Andrian UH; Jensen KF; Langer R; Knoetgen H; Trumpfheller C; Umaña P; Bernstein H; Sharei A; Loughhead SM
J Immunol; 2022 Feb; 208(4):929-940. PubMed ID: 35091434
[TBL] [Abstract][Full Text] [Related]
31. Murine dendritic cells transfected with human GP100 elicit both antigen-specific CD8(+) and CD4(+) T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity.
Yang S; Vervaert CE; Burch J; Grichnik J; Seigler HF; Darrow TL
Int J Cancer; 1999 Nov; 83(4):532-40. PubMed ID: 10508491
[TBL] [Abstract][Full Text] [Related]
32. Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory.
Hao S; Yuan J; Xiang J
J Leukoc Biol; 2007 Oct; 82(4):829-38. PubMed ID: 17626150
[TBL] [Abstract][Full Text] [Related]
33. Thymic but not splenic CD8⁺ DCs can efficiently cross-prime T cells in the absence of licensing factors.
Dresch C; Ackermann M; Vogt B; de Andrade Pereira B; Shortman K; Fraefel C
Eur J Immunol; 2011 Sep; 41(9):2544-55. PubMed ID: 21748731
[TBL] [Abstract][Full Text] [Related]
34. Effective Priming of Herpes Simplex Virus-Specific CD8
Whitney PG; Makhlouf C; MacLeod B; Ma JZ; Gressier E; Greyer M; Hochheiser K; Bachem A; Zaid A; Voehringer D; Heath WR; Wagle MV; Parish I; Russell TA; Smith SA; Tscharke DC; Gebhardt T; Bedoui S
J Virol; 2018 Feb; 92(3):. PubMed ID: 29142130
[TBL] [Abstract][Full Text] [Related]
35. Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma.
Goldszmid RS; Idoyaga J; Bravo AI; Steinman R; Mordoh J; Wainstok R
J Immunol; 2003 Dec; 171(11):5940-7. PubMed ID: 14634105
[TBL] [Abstract][Full Text] [Related]
36. Defective MHC class II presentation by dendritic cells limits CD4 T cell help for antitumor CD8 T cell responses.
Gerner MY; Casey KA; Mescher MF
J Immunol; 2008 Jul; 181(1):155-64. PubMed ID: 18566380
[TBL] [Abstract][Full Text] [Related]
37. Antigen targeting to CD11b allows efficient presentation of CD4+ and CD8+ T cell epitopes and in vivo Th1-polarized T cell priming.
Schlecht G; Loucka J; Najar H; Sebo P; Leclerc C
J Immunol; 2004 Nov; 173(10):6089-97. PubMed ID: 15528345
[TBL] [Abstract][Full Text] [Related]
38. Autophagy protein ATG5 regulates CD36 expression and anti-tumor MHC class II antigen presentation in dendritic cells.
Oh DS; Lee HK
Autophagy; 2019 Dec; 15(12):2091-2106. PubMed ID: 30900506
[TBL] [Abstract][Full Text] [Related]
39. Anatomic location defines antigen presentation by dendritic cells to T cells in response to intravenous soluble antigens.
Chung Y; Chang JH; Kim BS; Lee JM; Kim HY; Kang CY
Eur J Immunol; 2007 Jun; 37(6):1453-62. PubMed ID: 17474148
[TBL] [Abstract][Full Text] [Related]
40. Tumour-associated glycan modifications of antigen enhance MGL2 dependent uptake and MHC class I restricted CD8 T cell responses.
Singh SK; Streng-Ouwehand I; Litjens M; Kalay H; Saeland E; van Kooyk Y
Int J Cancer; 2011 Mar; 128(6):1371-83. PubMed ID: 20473945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
